Pages that link to "Q35165126"
Jump to navigation
Jump to search
The following pages link to MicroRNA-mediated drug resistance in breast cancer (Q35165126):
Displaying 50 items.
- Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? (Q26772219) (← links)
- miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression (Q28485384) (← links)
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway (Q28551191) (← links)
- Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm (Q30453423) (← links)
- Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer (Q33613644) (← links)
- Targeting Intracellular Calcium Signaling ([Ca2 ]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview (Q33737290) (← links)
- Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (Q34066078) (← links)
- Noncoding RNAs as novel biomarkers in prostate cancer (Q34176890) (← links)
- miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer (Q34273176) (← links)
- The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool (Q34576658) (← links)
- An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance (Q34753903) (← links)
- MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10. (Q36504323) (← links)
- Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. (Q37003304) (← links)
- Suppressive action of miRNAs to ARP2/3 complex reduces cell migration and proliferation via RAC isoforms in Hirschsprung disease (Q37056963) (← links)
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer (Q37059796) (← links)
- 5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells (Q37438076) (← links)
- Multidrug-resistant breast cancer: current perspectives (Q37593383) (← links)
- Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer (Q37620662) (← links)
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway (Q37625750) (← links)
- MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1. (Q37699375) (← links)
- Introduction to RNA-Seq and its applications to drug discovery and development (Q38243630) (← links)
- Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity (Q38244618) (← links)
- Role of miR-155 in drug resistance of breast cancer. (Q38368383) (← links)
- Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues. (Q38382024) (← links)
- The Role of MicroRNAs in the Chemoresistance of Breast Cancer (Q38574546) (← links)
- Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas (Q38663683) (← links)
- Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer (Q38731291) (← links)
- miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC). (Q38740398) (← links)
- Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells. (Q38800139) (← links)
- Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery (Q38812898) (← links)
- Mechanisms of tumor cell resistance to the current targeted-therapy agents. (Q38828353) (← links)
- Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. (Q38830657) (← links)
- miR-520h is crucial for DAPK2 regulation and breast cancer progression (Q38873872) (← links)
- MiRNAs-mediated cisplatin resistance in breast cancer (Q38905681) (← links)
- MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1. (Q38940572) (← links)
- miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma (Q38968441) (← links)
- MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets (Q39166706) (← links)
- Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer (Q39772391) (← links)
- miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling. (Q41440890) (← links)
- A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification (Q41455489) (← links)
- A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma (Q43666067) (← links)
- MicroRNA-378 enhances inhibitory effect of curcumin on glioblastoma (Q47101149) (← links)
- Role of micro-RNAs in breast cancer surgery. (Q47728281) (← links)
- Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85. (Q48256677) (← links)
- Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data (Q50068060) (← links)
- Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells (Q50080746) (← links)
- Functional miRNAs in breast cancer drug resistance. (Q55000578) (← links)
- Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors. (Q55026357) (← links)
- The role and mechanisms of action of microRNAs in cancer drug resistance (Q64237748) (← links)
- Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful? (Q84106643) (← links)